ILSE Intralase Corp (MM)

IntraLase Corp. (Nasdaq:ILSE), manufacturer of the ultra-fast laser that is revolutionizing refractive and corneal surgery, today announced that Shelley B. Thunen, executive vice president and chief financial officer, will make a presentation to investors and financial analysts during the Bank of America 2006 Specialty Pharmaceuticals Conference in Southampton, N.Y. The presentation is scheduled for Thursday, Aug. 10, 2006, at 10:30 a.m. Eastern. A live webcast of the audio portion of the presentation will be available on the Investor Relations News and Events section of the IntraLase Web site at www.intralase.com. A replay of the webcast will be available on the IntraLase Web site until Aug. 17, 2006. About IntraLase Corp. IntraLase designs, develops, and manufactures an ultra-fast laser that is revolutionizing refractive and corneal surgery by creating safe and more precise corneal incisions. Delivering on the promise of ophthalmic laser technology, the IntraLase FS laser, related software, and disposable devices replace the hand-held microkeratome blade used during LASIK surgery. The unsurpassed accuracy of IntraLase's computer-controlled femtosecond laser has been shown to improve safety profiles and visual outcomes when used during LASIK. Additionally, the IntraLase FS laser creates precision-designed intracorneal incisions that when combined can be used during lamellar and penetrating keratoplasties, and intrastromal ring implantation. IntraLase is presently in the process of commercializing applications of its technology in the treatment of corneal diseases that require corneal transplant surgery. The company's proprietary laser and disposable patient interfaces are presently marketed throughout the United States and 31 other countries. IntraLase has headquarters and manufactures its products in Irvine. For additional information, visit the company's Web site: www.intralase.com.